Ledger.Open graph →
SEC Form D · filed December 18, 2020

Pear Therapeutics, Inc

Offering
$112.0M
Sold
$112.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Andrew Schwab · Boston, MADirectorYuri Maricich · Boston, MAExecZack Lynch · Boston, MADirectorNancy Schlichting · Boston, MADirectorElena Viboch · Boston, MADirectorTimothy Petersen · Boston, MADirectorRonan O'Brien · Boston, MAExecChristopher Guiffre · Boston, MAExecCorey Mccann · Boston, MAExec · DirectorJulia Strandberg · Boston, MAExecMaven Fund GP Ii, LLC · LARKSPUR, CADirectorJohn D'Agostino · Boston, MAExec · DirectorEdward T. Minskoff · Westport, CTExecJason Fitzgerald · Boston, MADirectorJamie Star · Boston, MADirectorRobert M. Austin · San Francisco, CAExecAzam Pasha · Dubai, C0DirectorDaniel L. Delaney · San Francisco, CAExecAION Value Add II GP LLC · New York, NYDirectorMichael T. Willner · Westport, CTExecMichael Blitzer · New York, NYDirectorGuy Shanon · New York, NYDirectorVerena A. Lim · Singapore, U0Exec · DirectorDavid A. Baldwin · Singapore, U0DirectorChristopher E. Low · Singapore, U0ExecGeoff Ruddick · Grand Cayman, Cayman IslandsExecTim Jackson · San Diego, CADirectorCaskie Collet · San Francisco, CAExecJoseph Sherman · San Francisco, CAExecJeffrey D. Malec · CHICAGO, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗